Atom Investors’s OrthoPediatrics KIDS Stock Holding History

Atom Investors’s Portfolio KIDS Stock Details KIDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-20,276	Closed	-$1.09M	–	288
2022 Q1	$1.09M	Buy	20,276 +7,237	+56%	+$370K	0.51%	44
2021 Q4	$781K	Buy	13,039 +6,596	+102%	+$411K	0.13%	126
2021 Q3	$422K	Buy	+6,443	New	+$418K	0.03%	213
2020 Q3	–	Sell	-6,149	Closed	-$269K	–	562
2020 Q2	$269K	Buy	+6,149	New	+$277K	0.02%	330

Other funds holding KIDS

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NCGI

Next Century Growth Investors Plymouth, Minnesota $1.38B AUM 102.34% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Atom Investors's KIDS Position: Q2 2022 in Review

Atom Investors sold out of OrthoPediatrics (KIDS) in Q2 2022, closing a stake of 20,276 shares — an estimated $1.09M sold.

Atom Investors first reported a position in KIDS in Q2 2020 and held it in 4 quarters. The position peaked at $1.09M in Q1 2022. 117 funds tracked by Wall St. Rank hold KIDS as of Q2 2022.

Atom Investors reported no remaining OrthoPediatrics position as of Q2 2022 after selling out during the quarter.
Atom Investors sold 20,276 OrthoPediatrics shares in Q2 2022, an estimated $1.09M.
Atom Investors first reported a position in OrthoPediatrics in Q2 2020 and held it in 4 quarters.
Atom Investors's OrthoPediatrics position peaked at $1.09M in Q1 2022.
117 funds tracked by Wall St. Rank held OrthoPediatrics as of Q2 2022.

Based on Atom Investors's 13F filing for Q2 2022, filed 15 Aug 2022.